Neurodevelopment Outcome
11
3
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 11 trials
100.0%
+13.4% vs benchmark
18%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (11)
Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI
Micronutrient Enhancement for Development and Health in Adolescents - The MEDHA Study
Turkish Version of the BRIEF-Hammersmith Infant Neurological Examination (HINE)
Thyroxine Supplementation in Small for Gestational Age (SGA) Infants With Birth Weight <1500g and TSH 6-20 mIU/ml
Antenatal vs Postnatal Transport Team Positioning in Extremely Preterm Outborn Infants
Implementation Outcomes and Cost-effectiveness of Developmental Monitoring for Children Exposed to HIV
Impact of Hospital to Home: Optimizing Preterm Infant Environment for Surgical Neonates and Their Parents (H-HOPE)
The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes
Maternal Risk, Fetal-Neonatal Brain Connectivity, and Early Neurodevelopment: A Longitudinal Observational Study
Gut Microbiota Diversity: Wrong Message in Autism, Wrong Architecture in Formation
The Premature Gut Microbiome and the Influence on Neonatal Immunity, Brain Development and White Matter Injury